Table 2.
Characteristics of patients with suspected myocarditis and controls
| Parameter | Controls | Myocarditis patients | p-value |
|---|---|---|---|
| Number | 17 | 67 | n.a. |
| Females / Males | 6/11 | 18/49 | n.a. |
| Age [years] | 36 ± 12 | 37 ± 14 | .849 |
| Height [cm] | 178 ± 11 | 177 ± 9 | .788 |
| Weight [kg] | 77 ± 14 | 79 ± 14 | .671 |
| Heart rate [bpm] | 63 ± 15 | 65 ± 13 | .743 |
| Symptom duration before CMR [days] | n.a. | 4.8 ± 4.4 | n.a. |
| Initial TnT [μg/l] | n.a. | 3.0 ± 16.1 | n.a. |
| Initial NT-proBNP [pg/ml] | n.a. | 2380 ± 5535 | n.a. |
| Initial CK [U/l] | n.a. | 2942 ± 1719 | n.a. |
| Initial CRP [mg/l] | n.a. | 37.4 ± 43.5 | n.a. |
| LVa EDb volume / BSAc [ml/m2] | 81 ± 14 | 84 ± 21 | .486 |
| LV ESd volume / BSA [ml/m2] | 29 ± 8 | 33 ± 10 | .081 |
| LV ejection fraction [%] | 65 ± 5 | 62 ± 7 | .032 |
| LV ED wall mass / BSA [g/m2] (without papillary muscles) | 47 ± 11 | 54 ± 15 | .026 |
| T2-Ratio | 1.8 ± 1.4 | 2.2 ± 0.9 | .097 |
| ≥ 2 out of 3 LLCe [%] | 0 | 57 | n.a. |
| 1 out of 3 LLC [%] | 24 | 27 | n.a. |
| 0 out of 3 LLC [%] | 76 | 16 | n.a. |
a LV left ventricle, b ED end diastolic, c BSA body surface area, d ES end systolic, e LLC Lake Louise criteria
Statistical significant p values are printed in bold face